Dashboard PDUFA PDUFA History Dilution Watch Downside Radar Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...
Free to browse, no account needed Follow the companies behind these drugs with free AI briefings, catalyst countdowns and dilution alerts.

Fluocinolone Acetonide · Derma-Smoothe/Fs, Iluvien

Small molecule · Agonist · developed by Alimera Sciences

Approved FDA, Sep 2014
1 Registered trials

What is Fluocinolone Acetonide?

Fluocinolone acetonide is a corticosteroid. It is used topically for dermatologic inflammatory conditions and as an intravitreal implant for eye disease.

Summary written with AI from the sources listed at the end of this page.

At a glance

Also known as
Derma-Smoothe/Fs, Iluvien, Synalar, NSC-92339
Drug type
Small molecule
Mechanism
Agonist
Pathways
cellular signaling, immune function, inflammation, protein regulation
Therapy area
Ophthalmology
Developer
Alimera Sciences Inc
In trials of
ANIP
FDA status
Approved as Derma-Smoothe/Fs, Iluvien, Synalar (September 26, 2014), NDA201923 · FDA label
UNII
0CD5FD6S2M

✅ FDA-approved uses

From the indications section of the FDA label (version of Jun 9, 2026). Read the full label for the exact wording, limitations and safety information.

🧪 Clinical trials

TrialPhaseConditionStatusSponsor
NCT05486468 Phase 3 Uveitis Recruiting ANIP

Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.

Conditions studied

UveitisUveitis, AnteriorUveitis, IntermediateUveitis, Posterior

Sources

Updated Oct 11, 2026.

Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.